Herpes simplex type 2 infections--an update.
Marques
A R
AR
Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Straus
S E
SE
D000998:Antiviral Agents / Q000627:therapeutic use; D018890:Chemoprevention; D006558:Herpes Genitalis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control / Q000635:transmission / Q000821:virology; D018258:Herpesvirus 2, Human / Q000276:immunology / Q000502:physiology; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D014765:Viral Vaccines; D014779:Virus Replication
D000998:Antiviral Agents; D014765:Viral Vaccines